Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor ModelsFRONTIERS IN IMMUNOLOGYIF5.92021-11-1515OAAI
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeSCIENCE TRANSLATIONAL MEDICINEIF14.62021-07-14124OA
Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung CancerFRONTIERS IN ONCOLOGYIF3.32021-04-154OAAI
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapyTHERANOSTICSIF13.32021-01-0150OAAI
Combination of bempegaldesleukin and anti-CTLA-4 prevents metastatic dissemination after primary surgery or radiation therapy in a preclinical model of non-small cell lung cancerCANCER RESEARCHIF16.62020-08-151PRE
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial-Membrane-Coated Nanoparticles通过联合辐射和细菌膜包被的纳米颗粒开发原位癌症疫苗ADVANCED MATERIALSIF26.82019-09-16120OAAI
Ability of Molecular Targeted Radionucleotide Therapy and Anti-CTLA-4 to Prevent Spontaneous Metastases in a Preclinical Lewis Lung Carcinoma ModelINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-012OAAI
External Beam Radiotherapy Required for Tumor Regression When Using CpG-Oligodeoxynucleotide and Anti-OX40 in an Immunologically Cold Tumor ModelINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-09-011PREAI